These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2068695)

  • 1. Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease.
    Auffarth B; Postma DS; de Monchy JG; van der Mark TW; Boorsma M; Koëter GH
    Thorax; 1991 May; 46(5):372-7. PubMed ID: 2068695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
    Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
    Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of inhaled corticosteroids to modify bronchoconstrictor or bronchodilator responsiveness in middle-aged smokers with mild airflow obstruction.
    Watson A; Lim TK; Joyce H; Pride NB
    Chest; 1992 Feb; 101(2):350-5. PubMed ID: 1735253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trial of inhaled budesonide on airway responsiveness in smokers with chronic bronchitis.
    Engel T; Heinig JH; Madsen O; Hansen M; Weeke ER
    Eur Respir J; 1989 Nov; 2(10):935-9. PubMed ID: 2691278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow.
    Waalkens HJ; Gerritsen J; Koëter GH; Krouwels FH; van Aalderen WM; Knol K
    Thorax; 1991 Jul; 46(7):499-503. PubMed ID: 1877037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhaled budesonide on the relationships between symptoms, lung function indices and airway hyperresponsiveness in patients with allergic asthma.
    Molema J; van Herwaarden CL; Folgering HT
    Pulm Pharmacol; 1989; 1(4):179-85. PubMed ID: 2520343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma.
    Weiner P; Weiner M; Azgad Y
    Thorax; 1995 Dec; 50(12):1270-3. PubMed ID: 8553300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled budesonide therapy for patients with stable COPD.
    Weiner P; Weiner M; Azgad Y; Zamir D
    Chest; 1995 Dec; 108(6):1568-71. PubMed ID: 7497762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects.
    Bel EH; Timmers MC; Zwinderman AH; Dijkman JH; Sterk PJ
    Am Rev Respir Dis; 1991 Jan; 143(1):109-13. PubMed ID: 1986667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term treatment with inhaled budesonide or theophylline on lung function, airway reactivity and asthma symptoms.
    Dahl R; Larsen BB; Venge P
    Respir Med; 2002 Jun; 96(6):432-8. PubMed ID: 12117043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term treatment with inhaled cromoglycate and budesonide on bronchial hyperresponsiveness in patients with allergic asthma.
    Molema J; van Herwaarden CL; Folgering HT
    Eur Respir J; 1989 Apr; 2(4):308-16. PubMed ID: 2500361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled budesonide in chronic bronchitis. Effects on respiratory impedance.
    Wesseling GJ; Quaedvlieg M; Wouters EF
    Eur Respir J; 1991 Oct; 4(9):1101-5. PubMed ID: 1756844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of regular terbutaline on the airway response to inhaled budesonide.
    Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
    Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypodense eosinophil number relates to clinical severity, airway hyperresponsiveness and response to inhaled corticosteroids in asthmatic subjects.
    Kuo HP; Yu TR; Yu CT
    Eur Respir J; 1994 Aug; 7(8):1452-9. PubMed ID: 7957830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.
    Rutgers SR; Koëter GH; van der Mark TW; Postma DS
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):880-6. PubMed ID: 9517606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do patients with COPD benefit from treatment with inhaled corticosteroids?
    van Schayck CP; van Grunsven PM; Dekhuijzen PN
    Eur Respir J; 1996 Oct; 9(10):1969-72. PubMed ID: 8902451
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease.
    Pauwels RA; Löfdahl CG; Laitinen LA; Schouten JP; Postma DS; Pride NB; Ohlsson SV
    N Engl J Med; 1999 Jun; 340(25):1948-53. PubMed ID: 10379018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.